CASI Pharmaceuticals Inc (CASI) is higher by 4.68% in a Week, Should You Sell?

CASI Pharmaceuticals Inc (CASI) is near the top in its industry group according to InvestorsObserver. CASI gets an overall rating of 78. That means it scores higher than 78 percent of stocks. CASI Pharmaceuticals Inc gets a 91 rank in the Biotechnology industry. Biotechnology is number 15 out of 148 industries.

CASI has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on CASI!

See Full CASI Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 78 means the stock is more attractive than 78 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With CASI Pharmaceuticals Inc Stock Today?

CASI Pharmaceuticals Inc (CASI) stock has gained 6.1% while the S&P 500 has fallen -0.2% as of 9:43 AM on Wednesday, Feb 28. CASI is up $0.33 from the previous closing price of $5.48 on volume of 3,750 shares. Over the past year the S&P 500 is higher by 27.63% while CASI is up 201.04%. CASI lost -$3.00 per share the over the last 12 months. Click Here to get the full Stock Report for CASI Pharmaceuticals Inc stock.